Home/Investors/Novartis Venture Fund Novartis Venture Fund
Biotech Investor · 12 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Iaso Bio | phase-1 | — | Immunology, Autoimmune Diseases |
| F-star Therapeutics | Phase 2 | — | Oncology, Immunology |
| Granite Bio | Phase 1 | — | Inflammation, Autoimmunity |
| Carbon Biosciences | Pre-clinical | — | Cystic Fibrosis, Genetic Diseases |
| StrideBio | Phase 1 | — | Neurology, Cardiovascular |
| RhyGaze | Pre-clinical | — | Ophthalmology, Retinal Diseases |
| Enterprise Therapeutics | Phase 1 | — | Cystic Fibrosis, Asthma |
| SpliceBio | Phase 1 | — | Ophthalmology, Genetic Diseases |
| Tagworks Pharmaceuticals | Phase 1 | — | Oncology |
| MediScan | commercial | — | Oncology, Cardiovascular |
| BioSynthetics | phase-1 | — | Metabolic |
| NeuroHeal | phase-2 | — | Neuroscience, Regenerative Medicine |